By Amaris Elliott-EngelContactAll ArticlesThe Legal IntelligencerJune 17, 2013A federal judge has approved a $150 million settlement by GlaxoSmithKline of a 33-member direct purchaser class action over allegations the drugmaker monopolized the market for its nasal spray Flonase.
This article requires free registration to Law.com. Please sign in or register to read the full text.
No comments:
Post a Comment